Physiological Small Airways Dysfunction and the Bronchodilator Response in Adults With Asthma and Its Risk Factors: A Retrospective Analysis
Open Access
- 1 March 2025
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 18, 377-389
Abstract
Background: Physiological evidence of small airways dysfunction (SAD) is present in some patients with asthma and is associated with poor disease control. It is unclear if this represents a distinct phenotype of asthma or if it is an early manifestation of the disease. The study aimed to evaluate SAD in asthma and its clinical associations. Methods: A retrospective analysis of routinely collected health data obtained from adults referred for routine spirometric assessment as part of their clinical management. The Maximal Mid-Expiratory Flow (MMEF) z-scores were used to assess the prevalence and association factors for SAD. Pre- and post-bronchodilator data of MMEF and FEV1 in patients with and without SAD or airflow obstruction (AO) were analysed. Results: A total of 1094 patients were included. 366 (33.5%) had evidence of SAD of whom 261 (71.3%) also had AO. Current smokers were at an increased risk of having SAD (OR: 2.05; 95% CI: 1.43– 2.93). 214 patients had Bronchodilator response (BDR) data with 157 (73.4%) demonstrating BDR for MMEF and 121 (56.5%) for FEV1. SAD at baseline was associated with a significant BDR for FEV1 (OR of 3.59 (95% CI: 1.77– 7.57)) and MMEF (OR of 2.89 (95% CI: 1.41– 5.95)). Males were less likely to have a positive BDR for MMEF than females (OR of 0.46; 95% CI: 0.24– 0.89). Conclusion: SAD is common in asthma and is related to the presence of AO, cigarette smoking and is associated with increased BDR for both FEV1 and MMEF. The assessment of SAD in routine clinical practice may help identify airway impairment early for the initiation of targeted therapies.Keywords
This publication has 52 references indexed in Scilit:
- Impact of Biologic Therapy on the Small Airways Asthma PhenotypeLung, 2022
- FEF25-75% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF25-75% and FEV1%The Journal of Allergy and Clinical Immunology: In Practice, 2021
- Small Airway Dysfunction Links Asthma Severity with Physical Activity and Symptom ControlThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real lifePulmonary Pharmacology & Therapeutics, 2020
- Small Airway Dysfunction by Impulse Oscillometry in Symptomatic Patients with Preserved Pulmonary FunctionThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- Mepolizumab improves small airway function in severe eosinophilic asthmaRespiratory Medicine, 2019
- The prevalence of small airways disease in adult asthma: A systematic literature reviewRespiratory Medicine, 2016
- Bronchodilator response as a marker of poor asthma controlRespiratory Medicine, 2016
- Effects of formoterol or salmeterol on impulse oscillometry in patients with persistent asthmaJournal of Allergy and Clinical Immunology, 2016
- The Relationship of the Bronchodilator Response Phenotype to Poor Asthma Control in Children with Normal SpirometryThe Journal of Pediatrics, 2011